The initiation of the herpes simplex virus lytic replication cycle depends upon the coordinated expression of the viral (IE) immediate early genes. These genes are controlled by complex multiprotein enhancer assemblies that consists of viral and cellular components. Studies are designed to identify critical components and investigate their interactions and their biochemical functions in order to provide insights into the mechanisms that drive viral gene expression and lytic infection. The mammalian coactivator HCF-1 is one of the essential factors involved in both the assembly of the viral IE enhancer complex and the activation of IE gene transcription. Studies address functions of this coactivator during the viral lytic cycle as well as in normal cellular processes. The importance of both is underscored by the complex viral-cell interactions that impact the lytic and latent states of the viral life cycle. Previous studies have determined that HCF-1 functions as a component of chromatin modification complexes that are essential for modulating the chromatin status of the viral IE genes upon infection. Additionally, HCF-1 modulates chromatin during HSV-1 DNA replication indicating that the protein plays critical roles throughout the viral lytic replication cycle. In fiscal year 2017, additional HCF-1 associated complexes were identified that play critical roles in the viral IE gene regulatory paradigm and thus control viral lytic infection and reactivation from latency.

Project Start
Project End
Budget Start
Budget End
Support Year
24
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
Zip Code
Alfonso-Dunn, Roberto; Turner, Anne-Marie W; Jean Beltran, Pierre M et al. (2017) Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency. Cell Host Microbe 21:507-517.e5
Kristie, Thomas M (2016) Chromatin Modulation of Herpesvirus Lytic Gene Expression: Managing Nucleosome Density and Heterochromatic Histone Modifications. MBio 7:e00098-16
Kristie, Thomas M (2015) Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies. Virology 479-480:555-61
Arbuckle, Jesse H; Kristie, Thomas M (2014) Epigenetic repression of herpes simplex virus infection by the nucleosome remodeler CHD3. MBio 5:e01027-13
Hill, James M; Quenelle, Debra C; Cardin, Rhonda D et al. (2014) Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes. Sci Transl Med 6:265ra169
Vogel, Jodi L; Kristie, Thomas M (2013) The dynamics of HCF-1 modulation of herpes simplex virus chromatin during initiation of infection. Viruses 5:1272-91
Liang, Yu; Vogel, Jodi L; Arbuckle, Jesse H et al. (2013) Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. Sci Transl Med 5:167ra5
Liang, Yu; Quenelle, Debra; Vogel, Jodi L et al. (2013) A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency. MBio 4:e00558-12
Knipe, David M; Lieberman, Paul M; Jung, Jae U et al. (2013) Snapshots: chromatin control of viral infection. Virology 435:141-56
Kristie, Thomas M (2012) The rise of epigenetic targets for the development of novel antivirals. Expert Rev Anti Infect Ther 10:1359-61

Showing the most recent 10 out of 14 publications